Related Experiment Videos
High-speed liquid chromatography/tandem mass spectrometry using a monolithic column for high-throughput bioanalysis
1Stine-Haskell Research Center, DuPont Pharmaceuticals Company, PO Box 30, Newark, DE 19714, USA. Jing-Tao.Wu@dupontpharma.com
Rapid Communications in Mass Spectrometry : RCM
|June 19, 2001
Summary
Monolithic columns enable high-speed bioanalysis using liquid chromatography/tandem mass spectrometry (LC/MS/MS). This method achieves rapid, reproducible separations of plasma extracts, supporting efficient drug discovery.
Area of Science:
- Analytical Chemistry
- Chromatography
- Mass Spectrometry
Background:
- Increasing workload in drug screening necessitates faster, accurate bioanalytical methods.
- Conventional particulate High-Performance Liquid Chromatography (HPLC) columns present limitations in throughput.
- Demand for high-throughput analytical methodologies in drug discovery and development is growing.
Purpose of the Study:
- To evaluate monolithic columns as an alternative to particulate HPLC columns for rapid bioanalysis.
- To demonstrate the feasibility of high-speed liquid chromatography/tandem mass spectrometry (LC/MS/MS) for drug discovery support.
- To assess the performance and robustness of monolithic columns at high flow rates.
Main Methods:
- Utilized monolithic columns for chromatographic separations instead of conventional particulate HPLC columns.
- Employed high flow rates (6 mL/min) due to the lower pressure drop of monolithic columns.
- Analyzed plasma extracts using LC/MS/MS, measuring separation efficiency, signal/noise ratios, and reproducibility.
Main Results:
- Achieved baseline separation of multiple drug compounds in plasma extracts within one minute.
- Observed consistent separation efficiency and signal/noise ratios across varying flow rates (1-6 mL/min).
- Demonstrated high reproducibility in retention time, separation quality, peak response, and sensitivity over an overnight run.
Conclusions:
- Monolithic columns facilitate significantly reduced runtime in bioanalysis without compromising separation power.
- The developed high-speed LC/MS/MS method using monolithic columns is robust and reproducible.
- This approach effectively supports high-throughput drug discovery programs by enabling rapid and reliable bioanalysis.